Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model

References

• van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp’s method (van der Heijde modification). J Rheumatol 1995;22:1792–6
   PubMed Web of Science ®Google Scholar
• Combe B, Cantagrel A, Goupille P, et al. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 2003;30:2344–9
   PubMed Web of Science ®Google Scholar
• Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659–72
   PubMed Web of Science ®Google Scholar
• Patterson JW, Cheung PS, Ernest MJ. 3-Carboxy-5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide, a new prodrug for the antiarthritic agent 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide. J Med Chem 1992;35:507–10
   PubMed Web of Science ®Google Scholar
• Li EK, Tam LS, Tomlinson B. Leflunomide in the treatment of rheumatoid arthritis. Clin Ther 2004;26:447–59
   PubMed Web of Science ®Google Scholar
• Greene S, Watanabe K, Braatz-Trulson J, Lou L. Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide. Biochem Pharmacol 1995;50:861–7
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 2000;59:841–9
   PubMed Web of Science ®Google Scholar
• Kremer JM, Cannon GW. Benefit/risk of leflunomide in rheumatoid arthritis. Clin Exp Rheumatol 2004;22:S95–100
   Google Scholar
• Scott DL, Smolen JS, Kalden JR, et al. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis 2001;60:913–23
   PubMed Web of Science ®Google Scholar
• Sanders S, Harisdangkul V. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity. Am J Med Sci 2002;323:190–3
   PubMed Web of Science ®Google Scholar
• Eber E, Uhlig T, McMenamin C, Sly PD. Leflunomide, a novel immunomodulating agent, prevents the development of allergic sensitization in an animal model of allergic asthma. Clin Exp Allergy 1998;28:376–84
   PubMed Web of Science ®Google Scholar
• Xi H, Cun D, Xiang R, et al. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment? J Control Release 2013;169:73–81
   PubMed Web of Science ®Google Scholar
• Bertolini G, Aquino M, Biffi M, et al. A new rational hypothesis for the pharmacophore of the active metabolite of leflunomide, a potent immunosuppressive drug. J Med Chem 1997;40:2011–16
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Nguyen HT, Vaz AD, et al. In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes. Drug Metab Dispos 2003;31:1240–50
   PubMed Web of Science ®Google Scholar
• Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem Biol Interact 2004;149:69–79
   PubMed Web of Science ®Google Scholar
• Knox P, Levick JR, McDonald JN. Synovial fluid – its mass, macromolecular content and pressure in major limb joints of the rabbit. J Exp Physiol 1988;73:33–45
   PubMed Web of Science ®Google Scholar
• Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991;31:537–41
   PubMed Web of Science ®Google Scholar
• Rolf C, Engström B, Beauchard C, et al. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford) 1999;38:564–7
   PubMed Web of Science ®Google Scholar
• Kawadkar J, Pathak A, Kishore R, Chauhan MK. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 2013;39:569–78
   PubMed Web of Science ®Google Scholar
• Mills PC, Magnusson BM, Cross SE. Penetration of a topically applied nonsteroidal anti-inflammatory drug into local tissues and synovial fluid of dogs. Am J Vet Res 2005;66:1128–32
   PubMed Web of Science ®Google Scholar
• Shinkai N, Korenaga K, Mizu H, Yamauchi H. Intra-articular penetration of ketoprofen and analgesic effects after topical patch application in rats. J Control Release 2008;131:107–12
   PubMed Web of Science ®Google Scholar
• Patel M, Joshi A, Hassanzadeth H, et al. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits. Drug Dev Ind Pharm 2011;37:613–17
   PubMed Web of Science ®Google Scholar
• Todo H, Sugibayashi K. Skin penetration enhancement and control of topically applied drugs. Drug Deliv Syst 2005;20:452–9
   Google Scholar
• Sallam MA, Motawaa AM, Mortada SM. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion. Drug Dev Ind Pharm 2015;41:141–7
   PubMed Web of Science ®Google Scholar
• Pershing LK, Lambert LD, Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res 1990;7:170–5
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–18
   PubMed Web of Science ®Google Scholar
• Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations – an overview. Skin Pharmacol Appl Skin Physiol 2000;13:229–34
   PubMedGoogle Scholar
• Jung EC, Maibach HI. Animal models for percutaneous absorption. J Appl Toxicol 2015;35:1–10
   PubMed Web of Science ®Google Scholar
• Struyk L, Hawes GE, Chatila MK, et al. T cell receptors in rheumatoid arthritis. Arthritis Rheum 1995;38:577–89
   PubMed Web of Science ®Google Scholar
• Buckley CD. Science, medicine, and the future. Treatment of rheumatoid arthritis. BMJ 1997;315:236–8
   PubMed Web of Science ®Google Scholar
• Kinne RW, Palombo-Kinne E, Emmrich F. T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? Biochim Biophys Acta 1997;1360:109–41
   PubMed Web of Science ®Google Scholar
• Striebich CC, Falta MT, Wang Y, et al. Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis. J Immunol 1998;161:4428–36
   PubMed Web of Science ®Google Scholar
• Bilthariya U, Jain N, Rajoriya V, Jain AK. Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm 2015;41:95–104
   PubMed Web of Science ®Google Scholar
• Poulter LW, Duke O, Panayi GS, et al. Activated T lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies. Scand J Immunol 1985;22:683–90
   PubMed Web of Science ®Google Scholar
• Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729–35
   PubMed Web of Science ®Google Scholar
• Ziff M. Pathways of mononuclear cell infiltration in rheumatoid synovitis. Rheumatol Int 1989;9:97–103
   PubMed Web of Science ®Google Scholar
• Hoy MD, O'Donnell JL, Hart DN. Dual CD45RA, CD45RO positive T-lymphocytes within rheumatoid arthritic joints. Pathology 1993;25:167–73
   PubMed Web of Science ®Google Scholar
• van der Graaff WL, Prins AP, Niers TM, et al. Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford) 1999;38:214–20
   PubMed Web of Science ®Google Scholar
• Emery P. Disease modification in rheumatoid arthritis with leflunomide. Scand J Rheumatol Suppl 1999;112:9–14
   PubMedGoogle Scholar
• Bédouet L, Pascale F, Bonneau M, Laurent A. In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system. Drug Dev Ind Pharm 2015;41:85–94
   PubMed Web of Science ®Google Scholar